{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:18:29Z","timestamp":1795029509037,"version":"4.10.2"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI20C1496"],"award-info":[{"award-number":["HI20C1496"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI20C1496"],"award-info":[{"award-number":["HI20C1496"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2017M3A9F3041045"],"award-info":[{"award-number":["NRF-2017M3A9F3041045"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2017M3A9F3041045"],"award-info":[{"award-number":["NRF-2017M3A9F3041045"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Rheumatoid arthritis (RA) is a systemic chronic inflammatory disease that leads to joint destruction and functional disability due to the targeting of self-antigens present in the synovium, cartilage, and bone. RA is caused by a number of complex factors, including genetics, environment, dietary habits, and altered intestinal microbial flora. Microorganisms in the gut bind to nod-like receptors and Toll-like receptors to regulate the immune system and produce various metabolites, such as short-chain fatty acids (SCFAs) that interact directly with the host. <jats:italic>Faecalibacterium prausnitzii<\/jats:italic> is a representative bacterium that produces butyrate, a well-known immunomodulatory agent in the body, and this microbe exerts anti-inflammatory effects in autoimmune diseases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, <jats:italic>F. prausnitzii<\/jats:italic> was administered in a mouse model of RA, to investigate RA pathology and changes in the intestinal microbial flora. Using collagen-induced arthritic mice, which is a representative animal model of RA, we administered <jats:italic>F. prausnitzii<\/jats:italic> orally for 7\u00a0weeks.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The arthritis score and joint tissue damage were decreased in the mice administered <jats:italic>F. prausnitzii<\/jats:italic> compared with the vehicle-treated group. In addition, administration of <jats:italic>F. prausnitzii<\/jats:italic> reduced the abundance of systemic immune cells that secrete the pro-inflammatory cytokine IL-17 and induced changes in SCFA concentrations and the intestinal microbial flora composition. It also resulted in decreased lactate and acetate concentrations, an increased butyrate concentration, and altered compositions of bacteria known to exacerbate or improve RA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>These results suggest that <jats:italic>F. prausnitzii<\/jats:italic> exerts a therapeutic effect on RA by regulation of IL-17 producing cells. In addition, <jats:italic>F. prausnitzii<\/jats:italic> modify the microbial flora composition and short chain fatty acids in experimental RA mouse model.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13075-023-03118-3","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T12:02:33Z","timestamp":1690372953000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["Faecalibacterium prausnitzii alleviates inflammatory arthritis and regulates IL-17 production, short chain fatty acids, and the intestinal microbial flora in experimental mouse model for rheumatoid arthritis"],"prefix":"10.1186","volume":"25","author":[{"given":"Jeonghyeon","family":"Moon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Ram","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heejung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JooYeon","family":"Jhun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon-Yeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Won","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunju","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myeong Soo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geun Eog","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-La","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hwan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,26]]},"reference":[{"key":"3118_CR1","doi-asserted-by":"publisher","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","volume":"4","author":"JS Smolen","year":"2018","unstructured":"Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, Kavanaugh A, McInnes IB, Solomon DH, Strand V, Yamamoto K. Rheumatoid arthritis. Nat Rev Dis Primers. 2018;4:18001.","journal-title":"Nat Rev Dis Primers"},{"key":"3118_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12967-018-1541-4","volume":"16","author":"Y Yang","year":"2018","unstructured":"Yang Y, He X, Zhao R, Guo W, Zhu M, Xing W, Jiang D, Liu C, Xu X. Serum IFN-gamma levels predict the therapeutic effect of mesenchymal stem cell transplantation in active rheumatoid arthritis. J Transl Med. 2018;16:165.","journal-title":"J Transl Med"},{"key":"3118_CR3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3389\/fimmu.2019.00353","volume":"10","author":"K Chemin","year":"2019","unstructured":"Chemin K, Gerstner C, Malmstrom V. Effector functions of CD4+ T cells at the site of local autoimmune inflammation-lessons from rheumatoid arthritis. Front Immunol. 2019;10:353.","journal-title":"Front Immunol"},{"key":"3118_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41584-018-0109-2","volume":"15","author":"Z Chen","year":"2019","unstructured":"Chen Z, Bozec A, Ramming A, Schett G. Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis. Nat Rev Rheumatol. 2019;15:9\u201317.","journal-title":"Nat Rev Rheumatol"},{"key":"3118_CR5","doi-asserted-by":"publisher","first-page":"21789","DOI":"10.1073\/pnas.0912152106","volume":"106","author":"JP Jacobs","year":"2009","unstructured":"Jacobs JP, Wu HJ, Benoist C, Mathis D. IL-17-producing T cells can augment autoantibody-induced arthritis. Proc Natl Acad Sci U S A. 2009;106:21789\u201394.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3118_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.828933","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang J, He L, Li W, Lv S. A role of IL-17 in rheumatoid arthritis patients complicated with atherosclerosis. Front Pharmacol. 2022;13: 828933.","journal-title":"Front Pharmacol"},{"key":"3118_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102425","volume":"110","author":"JS Smolen","year":"2020","unstructured":"Smolen JS. Insights into the treatment of rheumatoid arthritis: a paradigm in medicine. J Autoimmun. 2020;110: 102425.","journal-title":"J Autoimmun"},{"key":"3118_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.779787","volume":"12","author":"J Zuo","year":"2021","unstructured":"Zuo J, Tang J, Lu M, Zhou Z, Li Y, Tian H, Liu E, Gao B, Liu T, Shao P. Glycolysis rate-limiting enzymes: novel potential regulators of rheumatoid arthritis pathogenesis. Front Immunol. 2021;12: 779787.","journal-title":"Front Immunol"},{"key":"3118_CR9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/BOR.0b013e32834ff2fd","volume":"24","author":"SE Gabriel","year":"2012","unstructured":"Gabriel SE, Crowson CS. Risk factors for cardiovascular disease in rheumatoid arthritis. Curr Opin Rheumatol. 2012;24:171\u20136.","journal-title":"Curr Opin Rheumatol"},{"key":"3118_CR10","doi-asserted-by":"publisher","first-page":"6180","DOI":"10.1038\/s41598-018-24279-1","volume":"8","author":"H Yang","year":"2018","unstructured":"Yang H, Bian S, Chen H, Wang L, Zhao L, Zhang X, Zhao Y, Zeng X, Zhang F. Clinical characteristics and risk factors for overlapping rheumatoid arthritis and Sjogren\u2019s syndrome. Sci Rep. 2018;8:6180.","journal-title":"Sci Rep"},{"key":"3118_CR11","doi-asserted-by":"crossref","unstructured":"Burggraaf B, van Breukelen-van der Stoep DF, de Vries MA, Klop B, Liem AH, van de Geijn GM, van der Meulen N, Birnie E, van der Zwan EM, van Zeben J, Castro Cabezas M. Effect of a treat-to-target intervention of cardiovascular risk factors on subclinical and clinical atherosclerosis in rheumatoid arthritis: a randomised clinical trial. Ann Rheum Dis. 2019;78:335-341.","DOI":"10.1136\/annrheumdis-2018-214075"},{"key":"3118_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102400","volume":"110","author":"HU Scherer","year":"2020","unstructured":"Scherer HU, Haupl T, Burmester GR. The etiology of rheumatoid arthritis. J Autoimmun. 2020;110: 102400.","journal-title":"J Autoimmun"},{"key":"3118_CR13","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41584-021-00585-3","volume":"17","author":"MM Zaiss","year":"2021","unstructured":"Zaiss MM, Joyce Wu HJ, Mauro D, Schett G, Ciccia F. The gut-joint axis in rheumatoid arthritis. Nat Rev Rheumatol. 2021;17:224\u201337.","journal-title":"Nat Rev Rheumatol"},{"key":"3118_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0283-6","volume":"51","author":"Y Maeda","year":"2019","unstructured":"Maeda Y, Takeda K. Host-microbiota interactions in rheumatoid arthritis. Exp Mol Med. 2019;51:1\u20136.","journal-title":"Exp Mol Med"},{"key":"3118_CR15","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/nm.3914","volume":"21","author":"X Zhang","year":"2015","unstructured":"Zhang X, Zhang D, Jia H, Feng Q, Wang D, Liang D, Wu X, Li J, Tang L, Li Y, et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med. 2015;21:895\u2013905.","journal-title":"Nat Med"},{"key":"3118_CR16","doi-asserted-by":"publisher","first-page":"e418","DOI":"10.1016\/S2665-9913(20)30064-3","volume":"2","author":"PM Wells","year":"2020","unstructured":"Wells PM, Adebayo AS, Bowyer RCE, Freidin MB, Finckh A, Strowig T, Lesker TR, Alpizar-Rodriguez D, Gilbert B, Kirkham B, et al. Associations between gut microbiota and genetic risk for rheumatoid arthritis in the absence of disease: a cross-sectional study. Lancet Rheumatol. 2020;2:e418\u201327.","journal-title":"Lancet Rheumatol"},{"key":"3118_CR17","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/s41423-021-00661-4","volume":"18","author":"W Yang","year":"2021","unstructured":"Yang W, Cong Y. Gut microbiota-derived metabolites in the regulation of host immune responses and immune-related inflammatory diseases. Cell Mol Immunol. 2021;18:866\u201377.","journal-title":"Cell Mol Immunol"},{"key":"3118_CR18","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","volume":"30","author":"D Zheng","year":"2020","unstructured":"Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res. 2020;30:492\u2013506.","journal-title":"Cell Res"},{"key":"3118_CR19","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","volume":"10","author":"D Parada Venegas","year":"2019","unstructured":"Parada Venegas D, De la Fuente MK, Landskron G, Gonzalez MJ, Quera R, Dijkstra G, Harmsen HJM, Faber KN, Hermoso MA. Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol. 2019;10:277.","journal-title":"Front Immunol"},{"key":"3118_CR20","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.jaci.2015.08.021","volume":"137","author":"H Song","year":"2016","unstructured":"Song H, Yoo Y, Hwang J, Na YC, Kim HS. Faecalibacterium prausnitzii subspecies-level dysbiosis in the human gut microbiome underlying atopic dermatitis. J Allergy Clin Immunol. 2016;137:852\u201360.","journal-title":"J Allergy Clin Immunol"},{"key":"3118_CR21","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3389\/fmicb.2018.00346","volume":"9","author":"R Martin","year":"2018","unstructured":"Martin R, Bermudez-Humaran LG, Langella P. Searching for the bacterial effector: the example of the multi-skilled commensal bacterium Faecalibacterium prausnitzii. Front Microbiol. 2018;9:346.","journal-title":"Front Microbiol"},{"key":"3118_CR22","doi-asserted-by":"crossref","unstructured":"Bodkhe R, Balakrishnan B, Taneja V. The role of microbiome in rheumatoid arthritis treatment. Ther Adv Musculoskelet Dis. 2019;11:1759720X19844632.","DOI":"10.1177\/1759720X19844632"},{"key":"3118_CR23","doi-asserted-by":"publisher","first-page":"23561","DOI":"10.1038\/srep23561","volume":"6","author":"CS de Paiva","year":"2016","unstructured":"de Paiva CS, Jones DB, Stern ME, Bian F, Moore QL, Corbiere S, Streckfus CF, Hutchinson DS, Ajami NJ, Petrosino JF, Pflugfelder SC. Altered mucosal microbiome diversity and disease severity in Sjogren syndrome. Sci Rep. 2016;6:23561.","journal-title":"Sci Rep"},{"key":"3118_CR24","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1097\/JIM.0000000000000192","volume":"63","author":"BL Cantarel","year":"2015","unstructured":"Cantarel BL, Waubant E, Chehoud C, Kuczynski J, DeSantis TZ, Warrington J, Venkatesan A, Fraser CM, Mowry EM. Gut microbiota in multiple sclerosis: possible influence of immunomodulators. J Investig Med. 2015;63:729\u201334.","journal-title":"J Investig Med"},{"key":"3118_CR25","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1186\/s12864-018-5313-6","volume":"19","author":"CB Fitzgerald","year":"2018","unstructured":"Fitzgerald CB, Shkoporov AN, Sutton TDS, Chaplin AV, Velayudhan V, Ross RP, Hill C. Comparative analysis of Faecalibacterium prausnitzii genomes shows a high level of genome plasticity and warrants separation into new species-level taxa. BMC Genomics. 2018;19:931.","journal-title":"BMC Genomics"},{"key":"3118_CR26","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/ismej.2016.176","volume":"11","author":"M Lopez-Siles","year":"2017","unstructured":"Lopez-Siles M, Duncan SH, Garcia-Gil LJ, Martinez-Medina M. Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics. ISME J. 2017;11:841\u201352.","journal-title":"ISME J"},{"key":"3118_CR27","doi-asserted-by":"publisher","first-page":"16731","DOI":"10.1073\/pnas.0804812105","volume":"105","author":"H Sokol","year":"2008","unstructured":"Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermudez-Humaran LG, Gratadoux JJ, Blugeon S, Bridonneau C, Furet JP, Corthier G, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A. 2008;105:16731\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3118_CR28","doi-asserted-by":"publisher","first-page":"5563","DOI":"10.1002\/jsfa.11207","volume":"101","author":"W Hu","year":"2021","unstructured":"Hu W, Lu W, Li L, Zhang H, Lee YK, Chen W, Zhao J. Both living and dead Faecalibacterium prausnitzii alleviate house dust mite-induced allergic asthma through the modulation of gut microbiota and short-chain fatty acid production. J Sci Food Agric. 2021;101:5563\u201373.","journal-title":"J Sci Food Agric"},{"key":"3118_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103798","volume":"76","author":"C Cantoni","year":"2022","unstructured":"Cantoni C, Lin Q, Dorsett Y, Ghezzi L, Liu Z, Pan Y, Chen K, Han Y, Li Z, Xiao H, et al. Alterations of host-gut microbiome interactions in multiple sclerosis. EBioMedicine. 2022;76: 103798.","journal-title":"EBioMedicine"},{"key":"3118_CR30","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1136\/gutjnl-2014-307649","volume":"65","author":"E Quevrain","year":"2016","unstructured":"Quevrain E, Maubert MA, Michon C, Chain F, Marquant R, Tailhades J, Miquel S, Carlier L, Bermudez-Humaran LG, Pigneur B, et al. Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn\u2019s disease. Gut. 2016;65:415\u201325.","journal-title":"Gut"},{"key":"3118_CR31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12967-022-03296-9","volume":"20","author":"P Gebrayel","year":"2022","unstructured":"Gebrayel P, Nicco C, Al Khodor S, Bilinski J, Caselli E, Comelli EM, Egert M, Giaroni C, Karpinski TM, Loniewski I, et al. Microbiota medicine: towards clinical revolution. J Transl Med. 2022;20:111.","journal-title":"J Transl Med"},{"key":"3118_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1826748","volume":"12","author":"M Lenoir","year":"2020","unstructured":"Lenoir M, Martin R, Torres-Maravilla E, Chadi S, Gonzalez-Davila P, Sokol H, Langella P, Chain F, Bermudez-Humaran LG. Butyrate mediates anti-inflammatory effects of Faecalibacterium prausnitzii in intestinal epithelial cells through Dact3. Gut Microbes. 2020;12:1\u201316.","journal-title":"Gut Microbes"},{"key":"3118_CR33","doi-asserted-by":"publisher","first-page":"18507","DOI":"10.1038\/srep18507","volume":"6","author":"O Rossi","year":"2016","unstructured":"Rossi O, van Berkel LA, Chain F, Tanweer Khan M, Taverne N, Sokol H, Duncan SH, Flint HJ, Harmsen HJ, Langella P, et al. Faecalibacterium prausnitzii A2\u2013165 has a high capacity to induce IL-10 in human and murine dendritic cells and modulates T cell responses. Sci Rep. 2016;6:18507.","journal-title":"Sci Rep"},{"issue":"74\u201398","key":"3118_CR34","volume":"2","author":"J Zhang","year":"2021","unstructured":"Zhang J, Huang YJ, Yoon JY, Kemmitt J, Wright C, Schneider K, Sphabmixay P, Hernandez-Gordillo V, Holcomb SJ, Bhushan B, et al. Primary human colonic mucosal barrier crosstalk with super oxygen-sensitive Faecalibacterium prausnitzii in continuous culture. Med (N Y). 2021;2(74\u201398): e79.","journal-title":"Med (N Y)"},{"key":"3118_CR35","doi-asserted-by":"publisher","first-page":"5201","DOI":"10.3748\/wjg.v22.i22.5201","volume":"22","author":"XL Huang","year":"2016","unstructured":"Huang XL, Zhang X, Fei XY, Chen ZG, Hao YP, Zhang S, Zhang MM, Yu YQ, Yu CG. Faecalibacterium prausnitzii supernatant ameliorates dextran sulfate sodium induced colitis by regulating Th17 cell differentiation. World J Gastroenterol. 2016;22:5201\u201310.","journal-title":"World J Gastroenterol"},{"key":"3118_CR36","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41586-020-2604-2","volume":"586","author":"SE Wu","year":"2020","unstructured":"Wu SE, Hashimoto-Hill S, Woo V, Eshleman EM, Whitt J, Engleman L, Karns R, Denson LA, Haslam DB, Alenghat T. Microbiota-derived metabolite promotes HDAC3 activity in the gut. Nature. 2020;586:108\u201312.","journal-title":"Nature"},{"key":"3118_CR37","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.3389\/fimmu.2018.01525","volume":"9","author":"DS Kim","year":"2018","unstructured":"Kim DS, Kwon JE, Lee SH, Kim EK, Ryu JG, Jung KA, Choi JW, Park MJ, Moon YM, Park SH, et al. Attenuation of rheumatoid inflammation by sodium butyrate through reciprocal targeting of HDAC2 in osteoclasts and HDAC8 in T cells. Front Immunol. 2018;9:1525.","journal-title":"Front Immunol"},{"key":"3118_CR38","doi-asserted-by":"crossref","unstructured":"Kang S, You HJ, Lee YG, Jeong Y, Johnston TV, Baek NI, Ku S, Ji GE. Production, structural characterization, and in vitro assessment of the prebiotic potential of butyl-fructooligosaccharides. Int J Mol Sci. 2020;21(2):445.","DOI":"10.3390\/ijms21020445"},{"issue":"1125\u20131136","key":"3118_CR39","volume":"167","author":"M Schirmer","year":"2016","unstructured":"Schirmer M, Smeekens SP, Vlamakis H, Jaeger M, Oosting M, Franzosa EA, Ter Horst R, Jansen T, Jacobs L, Bonder MJ, et al. Linking the Human gut microbiome to inflammatory cytokine production capacity. Cell. 2016;167(1125\u20131136): e1128.","journal-title":"Cell"},{"key":"3118_CR40","doi-asserted-by":"crossref","unstructured":"Pietrosimone KM, Jin M, Poston B, Liu P. Collagen-induced arthritis: a model for murine autoimmune arthritis. Bio Protoc. 2015;5(20):e1626.","DOI":"10.21769\/BioProtoc.1626"},{"key":"3118_CR41","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/nprot.2007.173","volume":"2","author":"DD Brand","year":"2007","unstructured":"Brand DD, Latham KA, Rosloniec EF. Collagen-induced arthritis. Nat Protoc. 2007;2:1269\u201375.","journal-title":"Nat Protoc"},{"key":"3118_CR42","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1002\/eji.200939578","volume":"39","author":"DL Asquith","year":"2009","unstructured":"Asquith DL, Miller AM, McInnes IB, Liew FY. Animal models of rheumatoid arthritis. Eur J Immunol. 2009;39:2040\u20134.","journal-title":"Eur J Immunol"},{"key":"3118_CR43","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1002\/art.23063","volume":"56","author":"JJ Inglis","year":"2007","unstructured":"Inglis JJ, Notley CA, Essex D, Wilson AW, Feldmann M, Anand P, Williams R. Collagen-induced arthritis as a model of hyperalgesia: functional and cellular analysis of the analgesic actions of tumor necrosis factor blockade. Arthritis Rheum. 2007;56:4015\u201323.","journal-title":"Arthritis Rheum"},{"key":"3118_CR44","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","volume":"46","author":"GS Firestein","year":"2017","unstructured":"Firestein GS, McInnes IB. Immunopathogenesis of rheumatoid arthritis. Immunity. 2017;46:183\u201396.","journal-title":"Immunity"},{"key":"3118_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102392","volume":"110","author":"MAM van Delft","year":"2020","unstructured":"van Delft MAM, Huizinga TWJ. An overview of autoantibodies in rheumatoid arthritis. J Autoimmun. 2020;110: 102392.","journal-title":"J Autoimmun"},{"key":"3118_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102611","volume":"119","author":"DS Kim","year":"2021","unstructured":"Kim DS, Woo JS, Min HK, Choi JW, Moon JH, Park MJ, Kwok SK, Park SH, Cho ML. Short-chain fatty acid butyrate induces IL-10-producing B cells by regulating circadian-clock-related genes to ameliorate Sjogren\u2019s syndrome. J Autoimmun. 2021;119: 102611.","journal-title":"J Autoimmun"},{"key":"3118_CR47","doi-asserted-by":"crossref","unstructured":"Zhou W, Zhang, Li Z, Jiang H, Li J, Ren R, Gao X, Li J, Wang X, Wang W, Yang Y. The fecal microbiota of patients with pancreatic ductal adenocarcinoma and autoimmune pancreatitis characterized by metagenomic sequencing. J Transl Med. 2021;19:215.","DOI":"10.1186\/s12967-021-02882-7"},{"key":"3118_CR48","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1194\/jlr.R036012","volume":"54","author":"G den Besten","year":"2013","unstructured":"den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res. 2013;54:2325\u201340.","journal-title":"J Lipid Res"},{"key":"3118_CR49","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12918-017-0430-4","volume":"11","author":"M Hoek","year":"2017","unstructured":"Hoek M, Merks RMH. Emergence of microbial diversity due to cross-feeding interactions in a spatial model of gut microbial metabolism. BMC Syst Biol. 2017;11:56.","journal-title":"BMC Syst Biol"},{"key":"3118_CR50","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.cmet.2014.10.016","volume":"20","author":"G Sharon","year":"2014","unstructured":"Sharon G, Garg N, Debelius J, Knight R, Dorrestein PC, Mazmanian SK. Specialized metabolites from the microbiome in health and disease. Cell Metab. 2014;20:719\u201330.","journal-title":"Cell Metab"},{"key":"3118_CR51","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1365-2036.2007.03562.x","volume":"27","author":"HM Hamer","year":"2008","unstructured":"Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther. 2008;27:104\u201319.","journal-title":"Aliment Pharmacol Ther"},{"key":"3118_CR52","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature12721","volume":"504","author":"Y Furusawa","year":"2013","unstructured":"Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, Nakanishi Y, Uetake C, Kato K, Kato T, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013;504:446\u201350.","journal-title":"Nature"},{"key":"3118_CR53","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3389\/fimmu.2017.01036","volume":"8","author":"M Kespohl","year":"2017","unstructured":"Kespohl M, Vachharajani N, Luu M, Harb H, Pautz S, Wolff S, Sillner N, Walker A, Schmitt-Kopplin P, Boettger T, et al. The microbial metabolite butyrate induces expression of Th1-associated factors in CD4(+) T cells. Front Immunol. 2017;8:1036.","journal-title":"Front Immunol"},{"key":"3118_CR54","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41467-019-13668-3","volume":"11","author":"I Martinez-Reyes","year":"2020","unstructured":"Martinez-Reyes I, Chandel NS. Mitochondrial TCA cycle metabolites control physiology and disease. Nat Commun. 2020;11:102.","journal-title":"Nat Commun"},{"issue":"136\u2013150","key":"3118_CR55","volume":"27","author":"T Wang","year":"2018","unstructured":"Wang T, Fahrmann JF, Lee H, Li YJ, Tripathi SC, Yue C, Zhang C, Lifshitz V, Song J, Yuan Y, et al. JAK\/STAT3-regulated fatty acid beta-oxidation is critical for breast cancer stem cell self-renewal and chemoresistance. Cell Metab. 2018;27(136\u2013150): e135.","journal-title":"Cell Metab"},{"key":"3118_CR56","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.smim.2007.10.011","volume":"19","author":"II Ivanov","year":"2007","unstructured":"Ivanov II, Zhou L, Littman DR. Transcriptional regulation of Th17 cell differentiation. Semin Immunol. 2007;19:409\u201317.","journal-title":"Semin Immunol"},{"key":"3118_CR57","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/cmi.2010.21","volume":"7","author":"S Xu","year":"2010","unstructured":"Xu S, Cao X. Interleukin-17 and its expanding biological functions. Cell Mol Immunol. 2010;7:164\u201374.","journal-title":"Cell Mol Immunol"},{"key":"3118_CR58","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3389\/fcimb.2019.00369","volume":"9","author":"Y Sun","year":"2019","unstructured":"Sun Y, Chen Q, Lin P, Xu R, He D, Ji W, Bian Y, Shen Y, Li Q, Liu C, et al. Characteristics of gut microbiota in patients with rheumatoid arthritis in Shanghai China. Front Cell Infect Microbiol. 2019;9:369.","journal-title":"Front Cell Infect Microbiol"},{"key":"3118_CR59","doi-asserted-by":"crossref","unstructured":"Lukovac S, Belzer C, Pellis L, Keijser BJ, de Vos WM, Montijn RC, Roeselers G: Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids. mBio. 2014;5(4):e01438\u201314.","DOI":"10.1128\/mBio.01438-14"},{"key":"3118_CR60","doi-asserted-by":"publisher","first-page":"6983","DOI":"10.1128\/AEM.01641-16","volume":"82","author":"JP Ouwerkerk","year":"2016","unstructured":"Ouwerkerk JP, van der Ark KCH, Davids M, Claassens NJ, Finestra TR, de Vos WM, Belzer C. Adaptation of Akkermansia muciniphila to the Oxic-Anoxic Interface of the Mucus Layer. Appl Environ Microbiol. 2016;82:6983\u201393.","journal-title":"Appl Environ Microbiol"},{"key":"3118_CR61","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1128\/JB.00074-13","volume":"195","author":"MC Figueiredo","year":"2013","unstructured":"Figueiredo MC, Lobo SA, Sousa SH, Pereira FP, Wall JD, Nobre LS, Saraiva LM. Hybrid cluster proteins and flavodiiron proteins afford protection to Desulfovibrio vulgaris upon macrophage infection. J Bacteriol. 2013;195:2684\u201390.","journal-title":"J Bacteriol"},{"key":"3118_CR62","doi-asserted-by":"crossref","unstructured":"Hevia A, Milani C, Lopez P, Cuervo A, Arboleya S, Duranti S, Turroni F, Gonzalez S, Suarez A, Gueimonde M, et al. Intestinal dysbiosis associated with systemic lupus erythematosus. mBio. 2014;5:e01548\u201301514.","DOI":"10.1128\/mBio.01548-14"},{"key":"3118_CR63","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0002-9343(01)00785-9","volume":"111","author":"A Nehra","year":"2001","unstructured":"Nehra A, Mehta RN, Encarnacion C. Bacteroides fragilis arthritis in a patient with sickle cell disease. Am J Med. 2001;111:161.","journal-title":"Am J Med"},{"key":"3118_CR64","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/clinids\/12.1.20","volume":"12","author":"P Rosenkranz","year":"1990","unstructured":"Rosenkranz P, Lederman MM, Gopalakrishna KV, Ellner JJ. Septic arthritis caused by Bacteroides fragilis. Rev Infect Dis. 1990;12:20\u201330.","journal-title":"Rev Infect Dis"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-023-03118-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-023-03118-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-023-03118-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T12:05:02Z","timestamp":1690373102000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-023-03118-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,26]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3118"],"URL":"https:\/\/doi.org\/10.1186\/s13075-023-03118-3","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,26]]},"assertion":[{"value":"4 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol for the study involving human participants was approved by the Institutional Review Board of Seoul St. Mary\u2019s Hospital. All patients\/participants provided written informed consent to participate in this study. The animal study protocol was approved by the Animal Research Ethics Committee of the Catholic University of Korea.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"130"}}